AONC — American Oncology Network Cashflow Statement
0.000.00%
Last trade - 00:00- $50.01m
- $189.83m
- $1.28bn
Annual cashflow statement for American Oncology Network, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 22 | -0.105 | 2.59 | -63.1 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0.69 | 1.68 | 10.9 | 24.1 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 12.1 | -34.8 | -27 | 12.1 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 37.2 | -26.3 | -6.78 | -18.1 |
| Capital Expenditures | -12.2 | -8.32 | -7.19 | -12.3 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -2.45 | -2.37 | -6.8 | -23.3 |
| Acquisition of Business | ||||
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -14.7 | -10.7 | -14 | -35.5 |
| Financing Cash Flow Items | -0.177 | -1.15 | -0.477 | -9.05 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 16.3 | 26.5 | 15.3 | 55.3 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 38.8 | -10.5 | -5.43 | 1.61 |